A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class – Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels – Hospital & Clinics, Retail Pharmacies, Others.
A research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market By Region (North America, Europe, Asia Pacific and Rest of the world) and By Country (U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia) for the historical period of 2013-2017 and forecast period of 2018-2023.
According to Azoth Analytics research report, “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) – By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)” global antidepressants market is projected to display a robust growth represented by a CAGR of 3.12 % during 2018 – 2023.
The segment of Selective Serotonin Reuptake Inhibitors (SSRIs) drug class witnessed growth at a noteworthy rate over the past few years and in the forecast period on the back of rising awareness related metal disorders, rising healthcare expenditures along with rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs market in 2017. Key factors driving the robust growth rate of North America region include rising healthcare expenditure, addition of new drugs, rising disposable incomes, rising number of hospitals and clinics etc.
Request a Free Sample of The Report: http://orbisresearch.com/contacts/request-sample/2084919
The report titled “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) – By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)” has covered and analysed the potential of Global Antidepressants Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressants drug. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Antidepressants Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antidepressant Drugs Market – Sizing and Growth
Analysis By Drugs Class – Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
Analysis By Sales Channels – Hospital & Clinics, Retail Pharmacies, Others
Regional Markets – North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antidepressant Drugs Market – Sizing and Growth
Analysis By Drugs Class – Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
Analysis By Sales Channels – Hospital & Clinics, Retail Pharmacies, Others
Country Analysis – U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antidepressant Drugs Market – Sizing and Growth
Analysis By Drugs Class – Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
Other Report Highlights
Market Dynamics – Drivers and Restraints
Market Trends
Porter Five Force Analysis
Policy and Regulatory Landscape
Company Analysis – Pfizer, GlaxoSmithKline, Allergan, Forest laboratories, Takeda, Novartis, Eli Lilly
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Buy The Report @ http://orbisresearch.com/contact/purchase/2084919
Major Points From The Table Of Contents:
Research Methodology
Executive Summary
Strategic Recommendations
Antidepressant Drugs Market Outlook
Global Antidepressant Drugs Market: Growth and Forecast
Global Antidepressant Drugs Market: By Drugs Class
Global Antidepressant Drugs Market: By Sales Channels
Global Antidepressant Drugs Market: Pipeline Analysis
Global Antidepressant Drugs Market: Regional Analysis
Market Dynamics 10.1. Drivers
Market Trends
Policy and Regulatory Landscape
Porter’s Five Forces Analysis – Antidepressant Drugs Market
SWOT Analysis – Antidepressant Drugs Market
Company Profiles
List of Tables
Table A: List of Major Antidepressant Drugs Include in SSRIs Class
Table B: Licenced Indication of SSRIs
Table C: List of Major Antidepressant Drugs Include in SNRIs Class
Table D: List of Major Antidepressant Drugs Include in MAOIs Class
Table E: List of Major Antidepressant Drugs Include in Tricyclic Class
Table F: List of Major Antidepressant Drugs Include in Tetracyclic Class
Table G: List of Major Antidepressant Drugs Include in Benzodiazepines
Table H: List of Major Antidepressant Drugs Include in Antipsychotics
Table I: Antidepressant Drugs Market Analysis, By Drug, Developer, Phase, Indication
Table J: Facts and Figures Driving High Demand of Antidepressants in United States Market
List of Figures
Figure 1: Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion)
Figure 2: Global YLDs of Depressive Disorders (2013-2016, %)
Figure 3: Global DALYs of Anxiety Disorders (2013-2016 %)
Figure 4: DALYs due to Mental and Substance Abuse (2016)
Figure 5: World Female Population, 2012-2016 (Million)
Figure 6: World Population 65 Years & Above (% of Total), 2012-2016
Figure 7: Global Unemployment (2016, 2017E, 2018F, (Millions)
Figure 8: Global Health Expenditure Per Capita, By Select Countries, (2016, USD)
Figure 9: Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
Figure 10: Global Antidepressant Drugs Market Size, By Value, 2018-2023 (USD Billion)
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello, Senior Manager – Client Engagements
Email: sales@orbisresearch.com
Phone: +1 (214) 884-6817, +9164101019
Address:4144N Central Expressway, Suite 600
City: Dallas
State: TX
Country: United States
Website: http://orbisresearch.com/reports/index/global-antidepressant-drugs-market-analysis-by-drugs-class-by-sales-channel-by-region-by-country-opportunities-and-forecasts-2018-2023-by-region-by-country-us-canada-uk-germany-china-india-japan-brazil-south-arabia